PremiumPress ReleasesInside Information: Announcement of the Results of Placing, the Issue Price and registration of Placing Shares with the Trade Register
Faron to Host Webcast to Discuss New Data From Phase I/II BEXMAB Study of Bexmarilimab and Provide Update on the Development Outlook for Next 6-9 Months